The Hill  |  October 14, 2021

Lawrence Gostin, a global health law professor at Georgetown University, applauded Califf’s “impeccable scientific credentials” but raised concerns about his ties to the pharmaceutical industry and potential shortfalls in his experience.

“Dr. Califf has most experience in academic medicine and has not led a major public health agency or been at the forefront of battles against infectious diseases,” Gostin said. “Overall, Dr Califf is a person of great stature and integrity, but he must be judged on making the FDA fiercely independent and especially on his leadership in the COVID-19 response.”

Read more here.